Perspectives for the Use of Bispecific Antibodies in the Third- and Subsequent-Line Therapies of Follicular Lymphoma (Resolution of Expert Panel)

DOI:

https://doi.org/10.21320/6nkr3a68
Perspectives for the Use of Bispecific Antibodies in the Third- and Subsequent-Line Therapies of Follicular Lymphoma (Resolution of Expert Panel)  
  1. -

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Downloads

Download data is not yet available.
2023-2

Downloads

Published

20.02.2024

Issue

Vol. 16 No. 2 (2023)
NEWS

How to Cite

Perspectives for the Use of Bispecific Antibodies in the Third- and Subsequent-Line Therapies of Follicular Lymphoma (Resolution of Expert Panel). Clinical Oncohematology. Basic Research and Clinical Practice. 2024;16(2):227–228. doi:10.21320/6nkr3a68.